Kyongbo Pharmaceutical Statistics

Total Valuation

KRX:214390 has a market cap or net worth of KRW 132.44 billion. The enterprise value is 217.75 billion.

Market Cap	132.44B
Enterprise Value	217.75B

Important Dates

The next estimated earnings date is Thursday, May 15, 2025.

Earnings Date	May 15, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

KRX:214390 has 23.91 million shares outstanding. The number of shares has decreased by -0.31% in one year.

Current Share Class	n/a
Shares Outstanding	23.91M
Shares Change (YoY)	-0.31%
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	17.13%
Owned by Institutions (%)	1.87%
Float	9.13M

Valuation Ratios

The trailing PE ratio is 28.56.

PE Ratio	28.56
Forward PE	n/a
PS Ratio	0.56
PB Ratio	0.91
P/TBV Ratio	0.93
P/FCF Ratio	n/a
P/OCF Ratio	888.19
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.13, with an EV/FCF ratio of -17.35.

EV / Earnings	46.94
EV / Sales	0.91
EV / EBITDA	10.13
EV / EBIT	23.99
EV / FCF	-17.35

Financial Position

The company has a current ratio of 1.15, with a Debt / Equity ratio of 0.63.

Current Ratio	1.15
Quick Ratio	0.44
Debt / Equity	0.63
Debt / EBITDA	4.00
Debt / FCF	-7.29
Interest Coverage	2.44

Financial Efficiency

Return on equity (ROE) is 3.19% and return on invested capital (ROIC) is 2.85%.

Return on Equity (ROE)	3.19%
Return on Assets (ROA)	2.38%
Return on Invested Capital (ROIC)	2.85%
Return on Capital Employed (ROCE)	6.91%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.87
Inventory Turnover	1.94

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -25.40% in the last 52 weeks. The beta is 1.29, so KRX:214390's price volatility has been higher than the market average.

Beta (5Y)	1.29
52-Week Price Change	-25.40%
50-Day Moving Average	5,888.80
200-Day Moving Average	6,942.80
Relative Strength Index (RSI)	48.90
Average Volume (20 Days)	20,601

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KRX:214390 had revenue of KRW 238.56 billion and earned 4.64 billion in profits. Earnings per share was 194.00.

Revenue	238.56B
Gross Profit	81.97B
Operating Income	10.45B
Pretax Income	4.90B
Net Income	4.64B
EBITDA	22.86B
EBIT	10.45B
Earnings Per Share (EPS)	194.00

Full Income Statement

Balance Sheet

The company has 6.13 billion in cash and 91.43 billion in debt, giving a net cash position of -85.30 billion or -3,568.22 per share.

Cash & Cash Equivalents	6.13B
Total Debt	91.43B
Net Cash	-85.30B
Net Cash Per Share	-3,568.22
Equity (Book Value)	146.15B
Book Value Per Share	6,106.13
Working Capital	19.28B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 149.12 million and capital expenditures -12.70 billion, giving a free cash flow of -12.55 billion.

Operating Cash Flow	149.12M
Capital Expenditures	-12.70B
Free Cash Flow	-12.55B
FCF Per Share	-524.85

Full Cash Flow Statement

Margins

Gross margin is 34.36%, with operating and profit margins of 4.38% and 1.94%.

Gross Margin	34.36%
Operating Margin	4.38%
Pretax Margin	2.06%
Profit Margin	1.94%
EBITDA Margin	9.58%
EBIT Margin	4.38%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 50.00, which amounts to a dividend yield of 0.90%.

Dividend Per Share	50.00
Dividend Yield	0.90%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	25.77%
Buyback Yield	0.31%
Shareholder Yield	1.21%
Earnings Yield	3.50%
FCF Yield	-9.47%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

KRX:214390 has an Altman Z-Score of 2.31. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.31
Piotroski F-Score	n/a